Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome, without effective therapy, characterized by diastolic dysfunction, a chronic low-grade inflammation and comorbidities such as hypertension. At the present time, few experimental models of HFpEF represent the hallmarks of patients. Recently, it has been described that the administration of a high-fat diet (HFD) in conjunction with an endothelial nitric oxide synthase inhibitor (L-NAME) can adequately reproduce the pathophysiological features of HFpEF. However, the effects on at renal level in HFpEF models have not been fully described. Our goal was to evaluate the kidney damage in a HFpEF model induced by HFD+L-NAME. Male C57BL/6N mice (12 weeks old, n=4-6) were treated with control diet or HFD (60% in fat calories) plus L-NAME (0.65 g/L in drinking water) for 15 weeks. We evaluated cardiac function (echocardiographic analysis), systolic blood pressure (SBP, plethysmography), cardiac and renal hypertrophy (morphometry and histology), plasma creatinine, blood urea nitrogen (BUN), plasma neutrophil gelatinase-associated lipocalin (pNGAL), proteinuria, and kidney immune cells infiltration (flow cytometry). All data are presented by mean±standard deviation. After 15 weeks of HFD+L-NAME we observed diastolic dysfunction (p<0.001), an increased SBP (control=128.0±15.3 vs. HFD+L-NAME=155.7±9.8 mmHg; p<0.01), without changes in ejection fraction and shortening fraction. In addition, we did not observe cardiac or renal hypertrophy, nor apparent histological changes in the renal structure between both groups of animals. No differences were found between groups regarding plasma creatinine, pNGAL or BUN, however, we observed that HFD+L-NAME induced proteinuria in compared to control mice (p<0.05). Finally, when we evaluated the immune cells population in kidney of both groups, we observed no differences in dendritic cells, macrophages, or neutrophils. Nevertheless, the HFD+L-NAME treatment was associated to a significant rising of Ly6G + CD11b - cells population (CD45 + MHC-II - CD11c +/- F4/80 - ) compared to control mice (p<0.05). In conclusion, our results indicate that there is no renal inflammatory damage after 15 weeks of in HFpEF experimental model. However, to our knowledge, an uncharacterized population of Ly6G cells could be participating at this stage which could trigger a long-term renal damage . FONDECYT 1221585 (MPO), 1231604 (JJ), 1231909 (CAA), 11241074 (PA) and FONDAP 15130011(MPO, LG).
Read full abstract